SRES 97 · 113th Congress 2013–2015, ended

A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

Fact sheet

Latest action · Apr 15, 2013 Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654)

Progress

Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A simple resolution is the business of one chamber alone: it is not sent to the other chamber or to the President, and does not become law.

  1. IntroducedApr 15, 2013
  2. Agreed to in SenateNot reached

Summary

Expresses the sense of the Senate that the Food and Drug Administration (FDA) should exercise its acknowledged authority to: (1) refuse to approve generic versions of non-abuse-deterrent opioid products that have been replaced in the market with abuse-deterrent formulations recognized by FDA as effective, and (2) require generic versions of abuse-deterrent opioid products to be formulated with comparable abuse-deterrent features.

Cosponsors 3

Members who signed on, in the order they did. Signatures ran from Apr 15, 2013 to Apr 16, 2013, with 2 there on the day it was introduced.

SeatCosponsorSigned on
D-NYCharles E. SchumerOriginalApr 15, 2013
R-KYMitch McConnellOriginalApr 15, 2013
R-TNLamar AlexanderApr 16, 2013

Actions 2

Everything that happened, newest first.

  1. Apr 15, 2013Introduced in Senate
  2. Apr 15, 2013Referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2654)

Related bills 1

Companion bills and other measures the record links to this one.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 15, 2013Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov.